Venmax Drugs and Pharmaceuticals Limited (BOM:531015)
India · Delayed Price · Currency is INR 25.90
-0.57 (-2.15%)
At close: Mar 27, 2026
BOM:531015 Market Cap
BOM:531015 has a market cap or net worth of 300 million as of March 27, 2026. Its market cap has increased by 195.17% in one year.
Market Cap
300.00M
Enterprise Value
318.93M
Revenue
44.14M
Ranking
n/a
PE Ratio
18.86
Stock Price
25.90
Market Cap Chart
Since April 15, 2008, BOM:531015's market cap has increased from 32.40M to 300.00M, an increase of 825.95%. That is a compound annual growth rate of 13.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 300.00M | 129.51% |
| Dec 31, 2025 | 130.71M | 38.30% |
| Dec 31, 2024 | 94.51M | 357.87% |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Smruthi Organics | 1.25B |
| Tyche Industries | 1.07B |
| Resonance Specialties | 1.04B |
| Krebs Biochemicals & Industries | 940.69M |
| Bacil Pharma | 695.69M |
| Alfavision Overseas (India) | 396.91M |
| Vasundhara Rasayans | 349.13M |
| Crestchem | 270.12M |